127 related articles for article (PubMed ID: 8692870)
1. A novel function for Myc: inhibition of C/EBP-dependent gene activation.
Mink S; Mutschler B; Weiskirchen R; Bister K; Klempnauer KH
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6635-40. PubMed ID: 8692870
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors.
Burk O; Mink S; Ringwald M; Klempnauer KH
EMBO J; 1993 May; 12(5):2027-38. PubMed ID: 8491193
[TBL] [Abstract][Full Text] [Related]
3. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types.
Ness SA; Kowenz-Leutz E; Casini T; Graf T; Leutz A
Genes Dev; 1993 May; 7(5):749-59. PubMed ID: 7684005
[TBL] [Abstract][Full Text] [Related]
4. Interaction of C/EBPbeta and v-Myb is required for synergistic activation of the mim-1 gene.
Mink S; Kerber U; Klempnauer KH
Mol Cell Biol; 1996 Apr; 16(4):1316-25. PubMed ID: 8657104
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal regulation of gadd45 by C/EBP alpha and c-Myc.
Tao H; Umek RM
DNA Cell Biol; 1999 Jan; 18(1):75-84. PubMed ID: 10025511
[TBL] [Abstract][Full Text] [Related]
6. The transcription activation domains of v-Myc and VP16 interact with common factors required for cellular transformation and proliferation.
Min S; Crider-Miller SJ; Taparowsky EJ
Cell Growth Differ; 1994 Jun; 5(6):563-73. PubMed ID: 8086335
[TBL] [Abstract][Full Text] [Related]
7. v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300.
Steinmann S; Schulte K; Beck K; Chachra S; Bujnicki T; Klempnauer KH
Oncogene; 2009 Jul; 28(26):2446-55. PubMed ID: 19448669
[TBL] [Abstract][Full Text] [Related]
8. High level activity of the mouse CCAAT/enhancer binding protein (C/EBP alpha) gene promoter involves autoregulation and several ubiquitous transcription factors.
Legraverend C; Antonson P; Flodby P; Xanthopoulos KG
Nucleic Acids Res; 1993 Apr; 21(8):1735-42. PubMed ID: 8493090
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal regulation of adipogenesis by Myc and C/EBP alpha.
Freytag SO; Geddes TJ
Science; 1992 Apr; 256(5055):379-82. PubMed ID: 1566086
[TBL] [Abstract][Full Text] [Related]
10. Cell transformation by the v-myc oncogene abrogates c-Myc/Max-mediated suppression of a C/EBP beta-dependent lipocalin gene.
Hartl M; Matt T; Schüler W; Siemeister G; Kontaxis G; Kloiber K; Konrat R; Bister K
J Mol Biol; 2003 Oct; 333(1):33-46. PubMed ID: 14516741
[TBL] [Abstract][Full Text] [Related]
11. Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta.
Clarkson RW; Chen CM; Harrison S; Wells C; Muscat GE; Waters MJ
Mol Endocrinol; 1995 Jan; 9(1):108-20. PubMed ID: 7760844
[TBL] [Abstract][Full Text] [Related]
12. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
13. Regulation of C/EBP beta/NF-M activity by kinase oncogenes.
Twamley-Stein G; Kowenz-Leutz E; Ansieau S; Leutz A
Curr Top Microbiol Immunol; 1996; 211():129-36. PubMed ID: 8585943
[TBL] [Abstract][Full Text] [Related]
14. Evidence for an enhanced transcription-dependent de novo synthesis of C/EBPbeta in the LPS activation of the chicken lysozyme gene.
Goethe R; Phi-van L
J Leukoc Biol; 1997 Mar; 61(3):367-74. PubMed ID: 9060461
[TBL] [Abstract][Full Text] [Related]
15. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.
Boruk M; Savory JG; Haché RJ
Mol Endocrinol; 1998 Nov; 12(11):1749-63. PubMed ID: 9817600
[TBL] [Abstract][Full Text] [Related]
16. C/EBPalpha and C/EBPdelta activate the clara cell secretory protein gene through interaction with two adjacent C/EBP-binding sites.
Cassel TN; Nordlund-Möller L; Andersson O; Gustafsson JA; Nord M
Am J Respir Cell Mol Biol; 2000 Apr; 22(4):469-80. PubMed ID: 10745028
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
Oelgeschläger M; Kowenz-Leutz E; Schreek S; Leutz A; Lüscher B
Oncogene; 2001 Nov; 20(50):7420-4. PubMed ID: 11704872
[TBL] [Abstract][Full Text] [Related]
18. Cell-free transcription directed by the 422 adipose P2 gene promoter: activation by the CCAAT/enhancer binding protein.
Cheneval D; Christy RJ; Geiman D; Cornelius P; Lane MD
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8465-9. PubMed ID: 1681537
[TBL] [Abstract][Full Text] [Related]
19. A dual activation mechanism for Myb-responsive genes in myelomonocytic cells.
Yamkamon V; Ivanova O; Braas D; Chayka O; Patmasiriwat P; Klempnauer KH
Blood Cells Mol Dis; 2008; 40(2):219-26. PubMed ID: 17950008
[TBL] [Abstract][Full Text] [Related]
20. v-Myc, but not Max, possesses domains that function in both transcription activation and cellular transformation.
Min S; Taparowsky EJ
Oncogene; 1992 Aug; 7(8):1531-40. PubMed ID: 1630816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
